Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (otvara novi prozor)

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

Izvor‎: Crit Care Med 2009;37(4):1299-307.

Indeks‎: PubMed 19242343

DOI‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 (otvara novi prozor)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (otvara novi prozor)

Ball AM, Winstead PS.

Izvor‎: Pharmacotherapy 2008;28(11):1383-90.

Indeks‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (otvara novi prozor)

Reducing postburn injury anemia in a Jehovah's Witness patient. (otvara novi prozor)

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

Izvor‎: J Burn Care Res 2014;35(4):e258-61.

Indeks‎: PubMed 24121804

DOI‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 (otvara novi prozor)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (otvara novi prozor)

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

Izvor‎: Clin Ther 2008;30(12):2324-34.

Indeks‎: PubMed 19167591

DOI‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 (otvara novi prozor)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (otvara novi prozor)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Izvor‎: Transplant Proc 2015;47(8):2548-51.

Indeks‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (otvara novi prozor)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (otvara novi prozor)

Charles A, Purtill M, Napolitano LM.

Izvor‎: Anaesth Intensive Care 2006;34(6):793-6.

Indeks‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (otvara novi prozor)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (otvara novi prozor)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Izvor‎: Crit Care Med 1999;27(11):2346-50.

Indeks‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (otvara novi prozor)

Erythropoietin for critically ill trauma patients: a missed opportunity? (otvara novi prozor)

Corwin HL, Napolitano LM

Izvor‎: J Trauma Acute Care Surg 2014;77(5):774-9.

Indeks‎: PubMed 25494432

DOI‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 (otvara novi prozor)

Postoperative management of severe acute anemia in a Jehovah's Witness. (otvara novi prozor)

de Araújo Azi LM, Lopes FM, Garcia LV

Izvor‎: Transfusion 2014;54(4):1153-7.

Indeks‎: PubMed 24117834

DOI‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 (otvara novi prozor)

Restrictive transfusion in geriatric trauma patients. (otvara novi prozor)

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

Izvor‎: Am Surg 2016;82(1):85-8.

Indeks‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 (otvara novi prozor)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (otvara novi prozor)

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

Izvor‎: J Trauma 1998;44(2):361-7.

Indeks‎: PubMed 9498512

DOI‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 (otvara novi prozor)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (otvara novi prozor)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Izvor‎: Crit Care 2005;9(5):R508-15.

Indeks‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (otvara novi prozor)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (otvara novi prozor)

Hong T, Shander A, Agarwal S, Castresana M.

Izvor‎: A A Case Rep 2015;4(10):127-31.

Indeks‎: PubMed 25974416

DOI‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 (otvara novi prozor)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (otvara novi prozor)

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

Izvor‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

Indeks‎: PubMed 35941026

DOI‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ (otvara novi prozor)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (otvara novi prozor)

Lindholm J, Palmér K, Frenckner B.

Izvor‎: Perfusion 2012;27(4):332-4.

Indeks‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (otvara novi prozor)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (otvara novi prozor)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Izvor‎: Am Surg 2010;76(9):951-6.

Indeks‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (otvara novi prozor)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (otvara novi prozor)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Izvor‎: Intensive Care Med 2013;39(11):1896-908.

Indeks‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (otvara novi prozor)

Transfusion-free treatment strategies for acute anemia in critical care. (otvara novi prozor)

Morgan CA, Byul Sarah S, Forest CP.

Izvor‎: JAAPA 2016;29(8):38-44.

Indeks‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (otvara novi prozor)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (otvara novi prozor)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Izvor‎: J Trauma 2008;65(2):285-97.

Indeks‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (otvara novi prozor)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (otvara novi prozor)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Izvor‎: J Trauma 2009;67(1):121-4.

Indeks‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (otvara novi prozor)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (otvara novi prozor)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Izvor‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Indeks‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (otvara novi prozor)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (otvara novi prozor)

Posluszny JA Jr, Napolitano LM.

Izvor‎: Transfusion 2014;54(12):3026-34.

Indeks‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (otvara novi prozor)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (otvara novi prozor)

Price S, Pepper JR, Jaggar SI.

Izvor‎: Anesth Analg 2005;101(2):325-7.

Indeks‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (otvara novi prozor)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (otvara novi prozor)

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

Izvor‎: Am Surg 2015;81(6):e263-5.

Indeks‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 (otvara novi prozor)

Erythropoietin response is blunted in critically ill patients. (otvara novi prozor)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Izvor‎: Intensive Care Med 1997;23(2):159-62.

Indeks‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (otvara novi prozor)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (otvara novi prozor)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Izvor‎: Br J Anaesth 2005;94(4):442-4.

Indeks‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (otvara novi prozor)

Management of anemia in patients who decline blood transfusion. (otvara novi prozor)

Shander A, Goodnough LT

Izvor‎: Am J Hematol 2018;93(9):1183-91.

Indeks‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (otvara novi prozor)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (otvara novi prozor)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Izvor‎: Arch Surg 2012;147(3):251-5.

Indeks‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (otvara novi prozor)

Intravenous iron following cardiac surgery does not increase the infection rate. (otvara novi prozor)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Izvor‎: Surg Infect (Larchmt) 2006;7(4):361-6.

Indeks‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (otvara novi prozor)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (otvara novi prozor)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Izvor‎: Crit Care 2015;19:49.

Indeks‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (otvara novi prozor)